Actavis PLC (NYSE:ACT)

Tuesday’s Trading Day
297.62 -7.14 / -2.34%
As of Mar 31
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
301.49 +3.87 / +1.30%
 
Volume: 14.8K

Today’s Trading

Previous close304.76
Today’s open303.52
Day’s range-- - --
Volume3,553,859
Average volume (3 months)3,258,903
Market cap$120.5B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+24.08%
Earnings growth (next 5 years)+14.95%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-1.05-2.22%
SNYSanofi-0.80-1.59%
NVONovo Nordisk-1.29-2.36%
BMYBristol-Myers Squibb-1.26-1.92%
Data as of 03/31/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$3.94
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account